Optimization of Plasmid Vectors for High-Level Expression in Lung Epithelial Cells
- 20 March 1997
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 8 (5) , 575-584
- https://doi.org/10.1089/hum.1997.8.5-575
Abstract
Nonviral gene therapy approaches use a plasmid vector to express the desired transgene. We have systematically examined several regulatory elements within plasmid vectors that govern gene expression, e.g., the promoter, enhancer, intron, and polyadenylation signal, by constructing a series of plasmids that differed only in the particular sequence element being evaluated. Of the several promoters and polyadenylation signal sequences that were tested, the human cytomegalovirus (CMV) immediate early gene promoter and the addition of polyadenylation signal sequences from the bovine growth hormone (BGH) gene or rabbit β-globin gene produced the highest levels of expression in vitro. The inclusion of a hybrid intron 3′ to the promoter further increased expression 1.6-fold. The addition of a region of the CMV enhancer 5′ to several weak promoters increased expression 8- to 67-fold, and co-transfection with a second plasmid encoding a chimeric transcription factor also enhanced expression. On the basis of these results, the CMV promoter, the hybrid intron, and the BGH polyadenylation signal were selected for consistent high level expression in vitro and in the mouse lung. However, expression was transient, with greater than 60% loss of activity in the first 7 days. This transient expression was not specific to CMV promoter-containing plasmids, because plasmids containing other heterologous promoters showed a similar profile of transient expression in vivo. These comparative analyses begin to provide a basis for the development of optimized expression plasmids for gene therapy of lung diseases. This study reports on our efforts to optimize plasmid vectors for cationic lipid-mediated gene therapy of cystic fibrosis. We have systematically evaluated several regulatory sequence elements within plasmid vectors that affect the level of gene expression in vitro and in vivo. The cytomegalovirus (CMV) immediate early gene promoter, a chimeric intron, and the bovine growth hormone polyadenylation signal were the sequence elements that resulted in the highest level of expression in cultured cells and in the mouse lung. The incorporation of an enhancer 5′ to several promoters and co-transfection of a second plasmid encoding a transcription factor also increased levels of expression. The transient profile of expression observed in the mouse lung was not specific to plasmids containing the CMV promoter.Keywords
This publication has 43 references indexed in Scilit:
- An Improved Plasmid DNA Expression Vector for Direct Injection into Skeletal MuscleHuman Gene Therapy, 1996
- Novel Polyaminolipids Enhance the Cellular Uptake of OligonucleotidesPublished by Elsevier ,1995
- A Novel Series of Amphiphilic Imidazolinium Compounds for in Vitro and in Vivo Gene DeliveryBiochemistry, 1995
- Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosisPublished by Elsevier ,1993
- Persistence of plasmid DNA and expression in rat brain cells in vivoExperimental Neurology, 1992
- In vitro polyadenylation is stimulated by the presence of an upstream intron.Genes & Development, 1990
- Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNAScience, 1989
- Definition of an efficient synthetic poly(A) site.Genes & Development, 1989
- GAL4-VP16 is an unusually potent transcriptional activatorNature, 1988
- Human GM-CSF: Molecular Cloning of the Complementary DNA and Purification of the Natural and Recombinant ProteinsScience, 1985